Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 1/20 | 0.49 |
| ▸ | FAP | Q12884 | 1/20 | 0.49 |
| ▸ | XIAP | P98170 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 12/20 | 0.42 |
| ▸ | MLX | Q9UH92 | 1/20 | 0.42 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.39 |
| ▸ | CTSG | P08311 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8961236 | 1.00 | PREP (0.49) | PREPFAPXIAPDPP4DPP8 | |
| SCHEMBL8922480 | 1.00 | PREP (0.49) | PREPFAPXIAPDPP4DPP8 | |
| SCHEMBL30582861 | 0.90 | XIAP (0.55) | XIAPELANEMLXCMA1CALCRL | |
| SCHEMBL8922544 | 0.89 | XIAP (0.47) | XIAPELANEMLXCMA1CTSG | |
| SCHEMBL8611726 | 0.89 | XIAP (0.47) | XIAPELANEMLXCMA1CTSG | |
| SCHEMBL8613939 | 0.87 | XIAP (0.57) | PREPFAPXIAPELANEMLX | |
| SCHEMBL8920341 | 0.87 | XIAP (0.57) | PREPFAPXIAPELANEMLX | |
| SCHEMBL30216504 | 0.87 | XIAP (0.52) | XIAPELANEMLXCMA1CALCRL | |
| SCHEMBL9622786 | 0.86 | PREP (0.49) | PREPFAPXIAPDPP4DPP8 | |
| SCHEMBL8920472 | 0.86 | CMA1 (0.53) | XIAPELANECMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287106-A1 | Method for Producing Fluorescent Probe Library Using Solid-Phase Extraction and Method of Measuring Enzyme Activity Using Same | RIKEN (JP) | 2024-08-29 | — | — | US | disclosed |
| EP-4353731-A1 | METHOD FOR PRODUCING FLUORESCENT PROBE LIBRARY USING SOLID-PHASE EXTRACTION AND METHOD OF MEASURING ENZYME ACTIVITY USING SAME | The University of Tokyo (JP) | 2024-04-17 | — | — | EP | disclosed |
| WO-2022260135-A1 | METHOD FOR PRODUCING FLUORESCENT PROBE LIBRARY USING SOLID-PHASE EXTRACTION AND METHOD OF MEASURING ENZYME ACTIVITY USING SAME | 国立大学法人 東京大学 | 2022-12-15 | — | — | WO | disclosed |
| EP-0693080-B1 | NEW GLUCOCORTICOIDS | SCHERING AG (DE) | 1998-04-22 | — | — | EP | disclosed |
| US-5616573-A | Glucocorticoids | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-04-01 | — | — | US | disclosed |
| EP-0693080-A1 | NEW GLUCOCORTICOIDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-01-24 | — | — | EP | disclosed |
| WO-1994022898-A1 | NEW GLUCOCORTICOIDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287106-A1 | Method for Producing Fluorescent Probe Library Using Solid-Phase Extraction and Method of Measuring Enzyme Activity Using Same | NOTUM, GUSB, RNGTT | PREP 26/4885FAP 267/4885XIAP 4212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.